We are live on ! Find out more
AG

Advisor Group Portfolio holdings

AUM $14.5B
1-Year Est. Return 24.86%
This Fund
S&P 500
This Quarter Est. Return
-11.22%
1 Year Est. Return
+24.86%
3 Year Est. Return
+39.54%
5 Year Est. Return
10 Year Est. Return
AUM
$10.2B
AUM Growth
+$266M
Cap. Flow
+$1.6B
Cap. Flow %
15.75%
Top 10 Hldgs %
19.6%
Holding
5,482
New
237
Increased
2,510
Reduced
1,723
Closed
201

Sector Composition

Rank Sector Weight
1 Technology 5.26%
2 Financials 4.59%
3 Healthcare 4.15%
4 Consumer Discretionary 3.48%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZUMZ icon
4776
Zumiez
ZUMZ
$320M
$2K ﹤0.01%
100
-474
-83% -$10K
SMC
4777
Summit Midstream
SMC
$421M
$2K ﹤0.01%
14
+1
+8% +$209
PRSU
4778
Pursuit Attractions and Hospitality Inc
PRSU
$1.43B
$2K ﹤0.01%
44
+18
+69% +$916
BLNE
4779
Beeline Holdings
BLNE
$30.6M
$2K ﹤0.01%
2
EVBN
4780
DELISTED
Evans Bancorp Inc
EVBN
$2K ﹤0.01%
75
CSSE
4781
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$2K ﹤0.01%
200
DSKE
4782
DELISTED
Daseke, Inc. Common Stock
DSKE
$2K ﹤0.01%
+500
New +$2.68K
NVTA
4783
DELISTED
Invitae Corporation
NVTA
$2K ﹤0.01%
200
-39
-16% -$505
TMDI
4784
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$2K ﹤0.01%
1,926
IVC
4785
DELISTED
Invacare Corporation
IVC
$2K ﹤0.01%
400
ASAP
4786
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$2K ﹤0.01%
+7
New +$1.59K
CHRA
4787
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$2K ﹤0.01%
+20
New +$1.44K
AERI
4788
DELISTED
Aerie Pharmaceuticals
AERI
$2K ﹤0.01%
73
-9
-11% -$422
HSTO
4789
DELISTED
Histogen Inc. Common Stock
HSTO
$2K ﹤0.01%
5
ISBC
4790
DELISTED
Investors Bancorp, Inc.
ISBC
$2K ﹤0.01%
235
+10
+4% +$115
FRTA
4791
DELISTED
Forterra, Inc
FRTA
$2K ﹤0.01%
600
DRNA
4792
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2K ﹤0.01%
200
GNMK
4793
DELISTED
GenMark Diagnostics, Inc
GNMK
$2K ﹤0.01%
410
+145
+55% +$755
EGOV
4794
DELISTED
NIC Inc
EGOV
$2K ﹤0.01%
145
+18
+14% +$240
CBMG
4795
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$2K ﹤0.01%
+100
New +$1.7K
ARA
4796
DELISTED
American Renal Associates Holdings, Inc
ARA
$2K ﹤0.01%
165
DNI
4797
DELISTED
Dividend and Income Fund
DNI
$2K ﹤0.01%
250
-118
-32% -$1.28K
STML
4798
DELISTED
Stemline Therapeutics, Inc.
STML
$2K ﹤0.01%
209
ARCH
4799
DELISTED
Arch Resources, Inc.
ARCH
$2K ﹤0.01%
+23
New +$2.04K
LTS
4800
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$2K ﹤0.01%
1,118

Similar funds

Advisor Group's Q4 2018 Portfolio in Review

As of Q4 2018, Advisor Group held 5,482 positions worth $10.2B, up 2.7% from $9.92B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Advisor Group deployed $1.6B of net new capital in Q4 2018, opening 237 new positions and adding to 2,510 existing holdings. Its largest new stake was AnaptysBio: 122,700 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 6.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Portfolio S&P 500 Growth ETF, an estimated $61M trimmed.

  • Advisor Group's largest Q4 2018 buy was AnaptysBio: 122,700 shares worth $7.83M.
  • Advisor Group added most to iShares Core S&P 500 ETF in Q4 2018, an estimated $134M increase.
  • Advisor Group's biggest Q4 2018 reduction was State Street SPDR Portfolio S&P 500 Growth ETF, cutting an estimated $61M.
  • Advisor Group fully exited Corporate Capital Trust, Inc. in Q4 2018, selling an estimated $12.1M.
  • Advisor Group's ten largest holdings make up 20% of its $10.2B portfolio in Q4 2018.
  • Advisor Group opened 237 new positions and closed 201 in Q4 2018.
  • Advisor Group's portfolio value rose 2.7% quarter-over-quarter to $10.2B.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.